Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Inhaler Testing

By Drug Discovery Trends Editor | February 9, 2010

The NGI cup coater is a new tool from Copley Scientific for use in semi-automated inhaler product testing.

The Next Generation Impactor (NGI) is used increasingly for aerodynamic particle size measurement, as prescribed by the regulators for all inhaled drug products. Applying a sticky layer to the cups of the impactor improves measurement accuracy, particularly for dry powder inhaler formulations, by reducing particle bounce and re-entrainment. Copley’s NGI cup coater automates this process replacing conventional coating methods such as spraying, dipping or pipetting, that are often manual, messy and time-consuming.

Automating the coating process frees up analysts to perform other tasks, eliminates the variability associated with a manual procedure and reduces solvent wastage. The cup coater is easy to use and holds a full set of 8 cups for simultaneous coating of all collection surfaces. The coating liquid, typically a solution of silicone oil, glycerol or PEG in a solvent such as hexane, is pumped into the rig to fill the cups and then the excess drawn out, the tray tilting to ensure the removal of all liquid. Fans assist in evaporating any remaining solvent leaving behind the sticky layer. The coating is dispensed in a fixed period of time, but the speed of the peristaltic pump used for filling and the drying time are variable, so the coating parameters can be adjusted in line with the viscosity of the solution.

Date: December 9, 2009
Source: Copley Scientific


Filed Under: Drug Discovery

 

Related Articles Read More >

Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
Labcorp widens precision oncology toolkit, aims to speed drug-trial enrollment
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE